About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 23, 2020... Dr. Nir London of the Weizmann Institute’s Department of Organic Chemistry explains his lab’s approach to fighting the coronavirus: creating a novel antiviral treatment. After identifying candidates for an antibody, he and his team are designing second-generation compounds that will go to colleagues in Germany and the U.K. for testing against the virus. Dr. London emphasizes the fact that this is open science: research that is freely available to all, for the benefit of everyone.
Mar 19, 2020... “This is the most important thing I can do,” says the Weizmann Institute’s Prof. Sarel Fleishman. His lab in the Department of Biomolecular Sciences was already studying SARS, which is, like COVID-19, a coronavirus. He is able to quickly apply his knowledge to developing computer models that allow him to design coronavirus antibodies – work that could lead to a vaccine.
Mar 19, 2020... In this videoconference, the Weizmann Institute’s Dr. Ron Diskin of the Department of Structural Biology, an expert in animal-borne viruses such as coronavirus, shares his insights on the current pandemic. A Q&A session with participants follows.
https://www.weizmann-usa.org/news-media/news-releases/two-steps-ahead-of-the-coronavirus/
Mar 22, 2020... REHOVOT, ISRAEL—March 22, 2020—A method for monitoring, identifying, and predicting where the coronavirus will spread has attracted considerable international interest. It was initiated and developed by scientists from the Weizmann Institute of Science, in collaboration with researchers from the Hebrew University of Jerusalem and Clalit Health Services and in coordination with Israel’s Ministry of Health. Other governments have now begun to implement the method, which is based on questionnaires for the general public and analysis of the data obtained from them. The questionnaires track the development of virus-induced symptoms, and the analysis relies on Big Data algorithms and artificial intelligence. Viral spread occurs in clusters of infection; thus, early identification of clusters may facilitate various actions aimed at slowing down the spread of the virus.
Jan 22, 2020...
Israeli scientists have discovered the effect of a gene in causing epilepsy and autism, which may lead to new therapies, the Weizmann Institute of Science (WIS) reported Thursday.
In a study published in the journal Nature Communications, the WIS researchers examined a non-coding gene, which is not translated into protein but replicated into control molecules.
The researchers found that by releasing the grip of this gene from another gene that produces proteins, the genetic defect responsible for these diseases can be corrected.
Jan 13, 2020...
A group of scientists led by a team from the Weizmann Institute of Science has devised a decoy molecule that could lead to the treatment of viruses that cross over from animals to humans.
A host of disease-causing viruses, which are called arenaviruses, “lurk in animal populations in various parts of the world, sometimes crossing over into humans,” the Rehovot-based Weizmann Institute said in a statement. “When they do cross over, they can be lethal, and only very few treatments exist.”
Mar 25, 2020... In this videoconference hosted by Weizmann Canada, Prof. Sarel Fleishman of the Weizmann Institute’s Department of Biomolecular Sciences gives a progress report on his lab’s coronavirus research. The coronavirus is so named because it is covered in “spikes” that look like the sun’s corona; Prof. Fleishman seeks to bind and neutralize the spike proteins, thus stopping the virus.
Mar 16, 2020... Prof. Gabi Barbash, Former Director General of Israel’s Ministry of Health and Director of the Weizmann Institute Bench-to-Bedside Program, which brings together scientists and physicians to fight disease, explains coronavirus from the perspective of public health. He also speaks to how it spreads and how it is different from other contagions.
Mar 25, 2020... In just one week, Profs. Ido Amit and Eran Elinav, both of the Department of Immunology, have built one of the highest-tech labs in the world. They developed a new type of PCR testing that is tremendously fast: if current capabilities test one patient at a time, the new method can test all of Israel simultaneously. The scientists intend to make their method available to anyone who needs it.
Mar 19, 2020... Dr. Noam Stern-Ginossar of the Weizmann Institute’s Department of Molecular Genetics provides an overview – complete with helpful cartoons – of basic questions: what is a virus? Why is coronavirus worse than the flu? (One reason – it’s new and so we have no immunity.) What are the issues related to developing a vaccine? (Mostly it’s time; otherwise, we know what to do, she reassures us.)
©2022 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR